GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biosenic (XBRU:BIOS) » Definitions » Dividend-Payout-to-FFO

Biosenic (XBRU:BIOS) Dividend-Payout-to-FFO


View and export this data going back to 2015. Start your Free Trial

What is Biosenic Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Biosenic (XBRU:BIOS) Business Description

Traded in Other Exchanges
Address
Rue Granbonpre 11, Batiment H (bte 24), Mont-St-Guibert, Gosselies, BEL, 1435
Biosenic is engaged in the development of cell therapy products for orthopaedics and bone diseases. The product pipeline of the company includes; ALLOB for treatment of delayed-union fractures, spinal fusion procedures and revision spinal fusion, and PREOB. In addition, the firm is also focused on conducting preclinical research on next-generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications.